Clinical Trial Update: A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating AMG 133 in Chinese participants with obesity or overweight has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AMG 133

Snippet

Sponsor: Amgen | Conditions: Obesity | Phase 1 | Status: COMPLETED